Medical University Innsbruck, Department of Internal Medicine V (Hematology and Oncology)

Innsbruck 6020

1 studies enrolling now · 3 studies all time

What they study most

DLBCL Transformed From Indolent Lymphoma, Diffuse Large B-cell Lymphoma, Follicular Grade 3 Lymphoma, MF, Multiple Myeloma, Myelofibrosis, Post-ET Myelofibrosis, Post-PV MF, Primary Myelofibrosis, de Novo DLBCL

Studies at this site

• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma — Completed
• Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant — Completed